Arsenic trioxide (As(2)O(3)) as a maintenance therapy for adult T cell leukemia/lymphoma

BACKGROUND: Adult T-cell leukemia-lymphoma (ATL) is an aggressive mature lymphoid proliferation associated with poor prognosis. Standard of care includes chemotherapy and/or the combination of zidovudine and interferon-alpha. However, most patients experience relapse less than 6 months after diagnos...

詳細記述

保存先:
書誌詳細
出版年:Retrovirology
主要な著者: Marçais, Ambroise, Cook, Lucy, Witkover, Aviva, Asnafi, Vahid, Avettand-Fenoel, Véronique, Delarue, Richard, Cheminant, Morgane, Sibon, David, Frenzel, Laurent, de Thé, Hugues, Bangham, Charles R. M., Bazarbachi, Ali, Hermine, Olivier, Suarez, Felipe
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2020
主題:
Short Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7085150/
https://ncbi.nlm.nih.gov/pubmed/32199462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12977-020-0513-y
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料